Alan S. Roemer - Net Worth and Insider Trading
Alan S. Roemer Net Worth
The estimated net worth of Alan S. Roemer is at least $16,584 dollars as of 2024-11-29. Alan S. Roemer is the Director of IN8bio Inc and owns about 55,989 shares of IN8bio Inc (INAB) stock worth over $16,584. Alan S. Roemer is also the Director of NexImmune Inc and owns about 0 shares of NexImmune Inc (NEXI) stock worth over $0. Details can be seen in Alan S. Roemer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alan S. Roemer has not made any transactions after 2023-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alan S. Roemer
Alan S. Roemer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alan S. Roemer owns 3 companies in total, including Sio Gene Therapies Inc (SIOX) , NexImmune Inc (NEXI) , and IN8bio Inc (INAB) .
Click here to see the complete history of Alan S. Roemer’s form 4 insider trades.
Insider Ownership Summary of Alan S. Roemer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SIOX | Sio Gene Therapies Inc | 2015-06-10 | Principal Fin & Acct Officer |
| NEXI | NexImmune Inc | 2023-11-22 | director |
| INAB | IN8bio Inc | 2022-08-16 | director |
Alan S. Roemer Latest Holdings Summary
Alan S. Roemer currently owns a total of 2 stocks. Among these stocks, Alan S. Roemer owns 55,989 shares of IN8bio Inc (INAB) as of August 16, 2022, with a value of $16,584 and a weighting of 100%. Alan S. Roemer also owns 0 shares of NexImmune Inc (NEXI) as of November 22, 2023, with a value of $0 and a weighting of 0%.
Latest Holdings of Alan S. Roemer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| INAB | IN8bio Inc | 2022-08-16 | 55,989 | 0.30 | 16,584 |
| NEXI | NexImmune Inc | 2023-11-22 | 0 | 0.41 | 0 |
Holding Weightings of Alan S. Roemer
Alan S. Roemer Form 4 Trading Tracker
According to the SEC Form 4 filings, Alan S. Roemer has made a total of 1 transactions in IN8bio Inc (INAB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IN8bio Inc is the acquisition of 26,315 shares on August 16, 2022, which cost Alan S. Roemer around $49,999.
According to the SEC Form 4 filings, Alan S. Roemer has made a total of 1 transactions in NexImmune Inc (NEXI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in NexImmune Inc is the sale of 7,825 shares on November 22, 2023, which brought Alan S. Roemer around $16,041.
Insider Trading History of Alan S. Roemer
- 1
Alan S. Roemer Trading Performance
GuruFocus tracks the stock performance after each of Alan S. Roemer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alan S. Roemer is -17.96%. GuruFocus also compares Alan S. Roemer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alan S. Roemer within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alan S. Roemer's insider trading performs compared to the benchmark.
Performance of Alan S. Roemer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 34.58 | | | | | |
| Relative Return to S&P 500(%) | 44.61 | | | | | |
Alan S. Roemer Ownership Network
Alan S. Roemer Owned Company Details
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
Alan S. Roemer is the Principal Fin & Acct Officer of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
Alan S. Roemer Mailing Address
Above is the net worth, insider trading, and ownership report for Alan S. Roemer. You might contact Alan S. Roemer via mailing address: C/o Axovant Sciences, Inc., 1441 Broadway, 3rd Floor, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
